Nephera

About:

Nephera is a development-stage medical device company focused on kidney function in congestive heart failure (CHF) patients.

Website: http://www.nephera.com

Twitter/X: NepheraLtd

Top Investors: Trendlines Group, Evergreen Venture Partners

Description:

Nephera (Israeli) a development-stage medical device company focused on kidney function in CHF patients. Nephera offers a treatment for acute heart failure patients by protecting kidney function through the modulation of sympathetic nerve activity. The company’s unique technology, in the exciting field of neurohormonal modulation, is based on electrical stimulation of the urinary tract for controlled inhibition of renal sympathetic nerve activity. The clinical outcome is preserved renal function and enhanced diuretic therapy.